Federal Register: February 18, 2004 (Volume 69, Number 32)
DOCID: FR Doc 04-3482
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
NOTICE: NOTICES
ACTION: Applications, hearings, determinations, etc.:
SUBJECT CATEGORY:
Manufacturer of Controlled Substances; Notice of Registration
DOCUMENT SUMMARY:
By notices dated March 11, 2003, and published in the Federal
Register on April 2, 2003 (68 FR 16088), dated April 3, 2003, and
published in the Federal Register on April 15, 2003 (68 FR 18262),
dated June 20, 2003, and published in the Federal Register on July 8,
2003 (68 FR 40686), and dated October 7, 2003, and published in the
Federal Register on October 29, 2003 (68 FR 61698), Cody Laboratories,
Inc., 331 33rd Street, Cody, Wyoming 82414, made application by letters
and by renewals to the Drug Enforcement Administration for registration
as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Dihydromorphine (9145)...................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Phenylacetone (8501)........................ II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Diphenoxylate (9170)........................ II
Meperidine (9230)........................... II
Oxymorphone (9652).......................... II
Sufentanil (9740)........................... II
Fentanyl (9801)............................. II
On December 30, 2003, the firm requested that their registration be modified to reflect an address change to 601 Yellowstone Drive, Cody, Wyoming 82414. That modification was effected on January 8, 2004.
The firm plans to manufacture bulk materials for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in title 21, United States Code, section 823(a) and
determined that the registration of Cody Laboratories, Inc. to
manufacture the listed controlled substances is consistent with the public
[[Page 7656]]
interest at this time. DEA has investigated Cody Laboratories, Inc. to
ensure that the company's registration is consistent with the public
interest. This investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR
0.100 and 0.104, the Deputy Assistant Administrator, Office of
Diversion Control, hereby orders that the application submitted by the
above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.
Dated: February 4, 2004.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 043482 Filed 21704; 8:45 am]
BILLING CODE 441009M
SUMMARY:
Cody Laboratories, Inc.,
DOCUMENT BODY 2:
By notices dated March 11, 2003, and published in the Federal
Register on April 2, 2003 (68 FR 16088), dated April 3, 2003, and
published in the Federal Register on April 15, 2003 (68 FR 18262),
dated June 20, 2003, and published in the Federal Register on July 8,
2003 (68 FR 40686), and dated October 7, 2003, and published in the
Federal Register on October 29, 2003 (68 FR 61698), Cody Laboratories,
Inc., 331 33rd Street, Cody, Wyoming 82414, made application by letters
and by renewals to the Drug Enforcement Administration for registration
as a bulk manufacturer of the basic classes of controlled substances listed below:
Drug Schedule Dihydromorphine (9145)...................... I
Amphetamine (1100).......................... II
Methamphetamine (1105)...................... II
Amobarbital (2125).......................... II
Pentobarbital (2270)........................ II
Secobarbital (2315)......................... II
Phenylacetone (8501)........................ II
Oxycodone (9143)............................ II
Hydromorphone (9150)........................ II
Diphenoxylate (9170)........................ II
Meperidine (9230)........................... II
Oxymorphone (9652).......................... II
Sufentanil (9740)........................... II
Fentanyl (9801)............................. II
On December 30, 2003, the firm requested that their registration be modified to reflect an address change to 601 Yellowstone Drive, Cody, Wyoming 82414. That modification was effected on January 8, 2004.
The firm plans to manufacture bulk materials for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in title 21, United States Code, section 823(a) and
determined that the registration of Cody Laboratories, Inc. to
manufacture the listed controlled substances is consistent with the public
[[Page 7656]]
interest at this time. DEA has investigated Cody Laboratories, Inc. to
ensure that the company's registration is consistent with the public
interest. This investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR
0.100 and 0.104, the Deputy Assistant Administrator, Office of
Diversion Control, hereby orders that the application submitted by the
above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed is granted.
Dated: February 4, 2004.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 043482 Filed 21704; 8:45 am]
BILLING CODE 441009M